For The Better

The alternative accommodations platform is registering solid growth.

Although no one doubts how dominant Apple is on a global stage, its investment merits might be limited.

This company is growing quickly and looks cheap.

These tech stocks have enormous growth potential thanks to rising demand for AI.

It may be best known for its diabetes treatment, Ozempic, but Novo Nordisk has a host of other blockbuster drugs, too.

Lucid stock is down 94% from its high. Could investors score massive wins by backing this heavily beaten-down stock?

These companies have done excellent jobs increasing their dividends over the years.

Check out how Zebra Technologies sprints ahead in AI innovation and what it means for investors.

Energy Transfer should be able to support its 9% dividend, but there is one major headwind investors need to understand.

Growing adoption of generative AI in this important industry could send this hard-charging tech stock higher.

The pain market is in great need of new options.

The company’s CEO is stepping down, and this analyst believes it’s a good thing.

These AI stocks have truly hit their stride. Is it time for some much-needed stock splits?

The master limited partnership could have massive upside potential.

Canopy Growth’s financials do appear to be going in the right direction, but is that enough for investors?

Lucid, Symbotic, and CrowdStrike could soar higher by the end of the decade.

These growth stocks are taking advantage of strong catalysts to increase their revenue and profits.

One longtime benefit of the stock now looks more like a burden.

One of the greatest hedge fund managers of his generation is going all-in on AI.

Fintech upstart SoFi turned a profit in the fourth quarter for the first time ever. Is it time to buy?